SRHU Adopts 300 patients under TB-free India campaign

Published on: May 22, 2023

Swami Rama Himalayan University Adopts 300 patients under TB-free India campaign

Facility of treatment and check-up will be given along with nutrition for one year

Dehradun, 13 May: Swami Rama Himalayan University has adopted three hunDr.ed patients under the Prime Minister’s TB-free India campaign run by the Government of India. These patients will be supported in treatment and investigation including nutrition.

Inaugurating the campaign on Saturday, Chancellor Dr. Vijay Dhasmana said that the institute has set a target of adopting 1000 TB patients. 300 TB patients will be given high protein nutrition kit every month for one year. Along with this, cooperation will also be given in the treatment and examination of these patients.

Rural Development Institute, Department of Community Medicine and Department of Respiratory and Chest Diseases will jointly conduct this program. This program will be run by the University in collaboration with this organization for health care of TB patients throughout the year.

Along with this, he underlined how the common man can contribute to TB-free India under the Ni-Kshaya Mitra scheme. He called upon everyone to make this program a success. Vice-Chancellor Dr. Vijender Chauhan said that TB-free India cannot be achieved by hospitals alone. For this, social institutions, individuals and experts will have to come forward and contribute. Speaking on the need of nutrition, he said that we cannot make India TB free with medicines without nutrition.

Deputy District Medical Officer Dr. Chandan Singh Rawat praised the university for its participation in this program and talked about providing expected cooperation. Dr. Rajeev Bijlwan, Deputy Director of Rural Development Department thanked everyone. He informed that under the campaign, 50 TB patients from Doiwala, 150 from Rishikesh and 100 from Bahadarabad will be provided nutrition, treatment and check-up facilities in the first phase.

Earlier in the program, Chancellor Dr. Vijay Dhasmana distributed high protein nutrition kit to TB patients. On this occasion, Dr. Jayanti Semwal, Dr. Rakhi Khanduri, Lakshmi and Hemlata threw light on other aspects of the program.

rdi-2
rdi-3
rdi-1
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.